HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raymond P Baumann Selected Research

O(6)-Methylguanine-DNA Methyltransferase

5/2015Antitumor sulfonylhydrazines: design, structure-activity relationships, resistance mechanisms, and strategies for improving therapeutic utility.
8/2014Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.
5/2014Influence of phosphate and phosphoesters on the decomposition pathway of 1,2-bis(methylsulfonyl)-1-(2-chloroethyhydrazine (90CE), the active anticancer moiety generated by Laromustine, KS119, and KS119W.
10/2012Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.
8/2012A strategy for selective O(6)-alkylguanine-DNA alkyltransferase depletion under hypoxic conditions.
11/20114-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.
5/2011KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O(6)-alkylguanine-DNA alkyltransferase in neoplastic cells.
11/2010Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase.
6/2010Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raymond P Baumann Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 01/2005
7Hypoxia (Hypoxemia)
02/2013 - 11/2008
6Carcinoma (Carcinomatosis)
01/2016 - 11/2008
3Leukemia
01/2016 - 01/2005
2Fanconi Anemia (Fanconi's Anemia)
01/2016 - 03/2012
2Glioma (Gliomas)
05/2011 - 11/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2008 - 01/2005
1Ovarian Epithelial Carcinoma
01/2016

Drug/Important Bio-Agent (IBA)

13ProdrugsIBA
01/2021 - 01/2005
9laromustine (VNP40101M)IBA
01/2018 - 01/2005
9O(6)-Methylguanine-DNA MethyltransferaseIBA
05/2015 - 06/2010
7DNA (Deoxyribonucleic Acid)IBA
01/2016 - 10/2008
6Oxygen (Dioxygen)IBA
08/2012 - 11/2008
5Proteins (Proteins, Gene)FDA Link
05/2015 - 11/2011
5hydrazine (hydrazine dihydrochloride)IBA
11/2011 - 01/2005
4GuanineIBA
06/2013 - 11/2010
3Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 02/2013
3Carmustine (FIVB)FDA Link
08/2014 - 11/2010
3Temozolomide (Temodar)FDA LinkGeneric
06/2013 - 11/2010
3O(6)-benzylguanineIBA
02/2013 - 11/2011
3EnzymesIBA
11/2011 - 11/2008
31,2- bis(methylsulfonyl)- 1- - (2- chloroethyl)- 2- ((1- (4- nitrophenyl)ethoxy)carbonyl)hydrazineIBA
10/2011 - 11/2008
2Alkylating AgentsIBA
06/2013 - 11/2010
2Alkyl and Aryl TransferasesIBA
02/2013 - 10/2012
2Oxidoreductases (Dehydrogenase)IBA
11/2011 - 05/2011
1Paclitaxel (Taxol)FDA LinkGeneric
01/2016
1Carboplatin (JM8)FDA LinkGeneric
01/2016
1Cisplatin (Platino)FDA LinkGeneric
01/2016
1PlatinumIBA
01/2016
13-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2016
1IsoenzymesIBA
08/2014
1MethyltransferasesIBA
06/2013
1Superoxides (Superoxide)IBA
10/2012
17-nitro-4-(phenylthio)benzofurazanIBA
10/2012
1Pharmaceutical PreparationsIBA
10/2012
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2012
1DNA alkyltransferaseIBA
08/2012
1TransferasesIBA
03/2012
1Cytotoxins (Cytolysins)IBA
10/2011
1AnnexinsIBA
01/2005
1methyl isocyanateIBA
01/2005

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2016
1Radiotherapy
03/2012